Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
  • Advertisement
    Companies

    Healthcare & Fitness

    Today

    Chemist Warehouse is expected to sell off part of its store network to convince the ACCC that the merger will not lead to higher prices for consumers.

    Competition regulator delays $8.8b Chemist Warehouse deal approval

    The ACCC is undertaking more analysis of the transaction, which would merge the pharmacy giant into Sigma Healthcare. A decision won’t be made until October.

    • 1 hr ago
    • Michael Smith

    This Month

    Former banker Peter Hunt and JJ Wilson, the 35-year-old son of billionaire Chip Wilson, who founded the Lululemon yoga apparel empire, are pioneering the psychedelic treatment industry in Australia.

    Psychedelics as a serious investment? These billionaires think so

    Australia is among the first countries to use the drugs for treating anxiety, depression and PTSD. A decision in the United States could be pivotal.

    • Michael Smith
    Dr Alex Abrahams voted against the NDC/Crescent Capital buyout of Pacific Smiles, and that was enough to kill the deal after Genesis Capital also voted its 19.9 per cent stake against it.

    Pacific Smiles shares tumble as $327m buyout plan fails

    Kingmaker Dr Alex Abrahams, a co-founder of dentistry group Pacific Smiles, voted his 9.5 per cent stake against the Crescent Capital offer, helping to kill it.

    • Simon Evans
    Radiology giant I-MED already has nearly 25 per cent market share in Australia, with half of its revenue coming from Medicare.

    Switzerland’s Unilabs takes a look at $4b I-MED radiology business

    The company’s British private equity owners, Permira, brought in Morgan Stanley and Jefferies earlier this year to work on plans for a bumper payday.

    • Sarah Thompson, Kanika Sood and Emma Rapaport
    Pfizer’s Australian boss Anne Harris says more funding is needed to give Australians access to drugs to counter fatal superbugs.

    Pfizer invests $150m in Melbourne to fight superbugs

    The US pharma giant says the federal government must do more to ensure Australians can access new drugs designed to fight deadly superbugs.

    • Michael Smith
    Advertisement
    Ramsay Health Care says full-year earnings will be weaker than expected, highlighting the challenges facing new chief executive Ntalie Davis.

    Ramsay tips lower earnings, hospital capex weak

    Ramsay Health Care says full-year earnings will be weaker than expected as it flags writedowns on its European operations.

    • Michael Smith
    Dr Rachel David, chief executive of Private Healthcare Australia, says a push to collective boycott insurers will hurt regional Australia

    Hospitals seek right to boycott big insurers from funding talks

    Catholic-operated private hospitals want a major shake-up of the way they negotiate funding deals with health insurers, in an escalation of tensions between the two sides.

    • Michael Smith
    Entrepreneur Craig Silbery sold the Life-Space group for $690 million to Chinese giant By-Health in 2018 and then had to stay out of the industry for five years under a no-compete clause. He build three businesses in the dog health industry in the meantime, and has now returned to probiotics.

    Entrepreneur returns with buyout after five-year non-compete clause

    Craig Silbery funded his first business on a credit card and 12 years later sold it for $690 million to a Chinese giant. He aims to repeat the growth with a probiotics business acquired after a forced five years out of the industry.

    • Simon Evans
    ResMed chief executive Mick Farrell in the dual-listed company’s headquarters in San Diego.

    ResMed says sales growth defies weight-loss fears

    Chief executive Mick Farrell says he is confident the company has put to bed investor fears that weight-loss drugs will hurt sales of its sleep apnoea products.

    • Michael Smith
    The report recommends reducing vascular risk factors such as obesity from unhealthy diets.

    High cholesterol critical factor in development of dementia, study finds

    Scientists have for the first time linked high cholesterol and vision loss to the onset of dementia, including them among 14 risk factors.

    • Sarah Neville
    Genesis Capital dealmakers Chris Yoo and Michael Caristo.

    Genesis remains defiant on blocking Crescent’s Pacific Smiles bid

    Street Talk understands Genesis Capital isn’t done yet and will continue to use its considerable stake to thwart the bid.

    • Sarah Thompson, Kanika Sood and Emma Rapaport
    Dr Alex Abrahams is the kingmaker in the battle for Pacific Smiles with 11.5 per cent of the dentistry group.

    Crescent Capital returns with $327m bid for Pacific Smiles

    The battle between private equity players Genesis and Crescent took another twist, with the owner of the National Dental Care network lifting its offer.

    • Simon Evans
    Genesis Capital’s $1.90 bid for Pacific Smiles had been deemed a “superior proposal”.

    Crescent set to come back with knockout bid for Pacific Smiles

    Street Talk understands Michael Alscher has come back fighting overnight, expected to increase the firm’s bid north of $2 per share.

    • Sarah Thompson, Kanika Sood and Emma Rapaport

    July

    It isdealmakers at 10 paces in the battle for a below-the-radar small cap.

    The PE takeover battle that is like pulling teeth

    Once a board has decided a takeover isn’t about the highest price, it enters the deal-making twilight zone. This one is a doozy.

    • Anthony Macdonald
    Genesis Capital’s offer for dentistry group Pacific Smiles has been deemed a “superior proposal” even though it is lower than a recommended offer by NDC/Crescent Capital.

    Pacific Smiles board says lower private equity offer is better

    A shareholder vote on a $305m buyout has been postponed, with the onus back on Crescent Capital to make a counter-proposal for the dentistry group.

    • Simon Evans
    Advertisement
    n 2020, there was a global rush to secure masks to try to restrict the spread of COVID-19 – some of the results were far from satisfactory.

    Importers got rich on COVID masks; the shipment’s still on the dock

    When COVID-19 erupted around the world, the race was on to secure masks and gowns. Middlemen were in lucrative taxpayer deals, even one which went awry.

    • Liam Walsh and Neil Chenoweth
    NIB Holdings CEO Mark Fitzgibbon has sympathy for private hospital operators.

    How to end the $22b private health war

    Many things have changed in the 22 years that Mark Fitzgibbon has spent at the helm of NIB. The tension between private health insurers and private hospitals isn’t one of them.  

    • Updated
    • James Thomson
    Dr Alex Abrahams is the kingmaker in the buyout of Pacific Smiles, which he co-founded 21 years ago.

    Genesis Capital ups bid in private equity battle for Pacific Smiles

    The kingmaker in the battle for Pacific Smiles and its 136 dental centres is co-founder Alex Abrahams, who expects more “twists and turns” to come.

    • Simon Evans
    Health Minister Mark Butler and Ramsay Health Care’s Australia boss, Carmel Monaghan, are key figures in working to resolve the financial crisis in private hospitals.

    Inside the stoush between private hospitals and health insurers

    As finances deteriorate, insurers and providers are slugging it out over how to overhaul a healthcare system which has not seen serious reform in decades.

    • Michael Smith
    The robotics surgery industry is growing at a 17 per cent compound annual growth rate.

    Robotics surgery trainer IMRA Surgical seeks growth capital

    Rather than an IPO, its owners are understood to be seeking a private sale in three to four years, once the business has reached profitability.

    • Sarah Thompson, Kanika Sood and Emma Rapaport